Progressive Keratoconus
3
Pipeline Programs
1
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
2
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
GlaukosALISO VIEJO, CA
3 programs1
2
Test Article APhase 31 trial
riboflavin ophthalmic solutionPhase 31 trial
NXL Energy 1Phase 1/21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
GlaukosTest Article A
Glaukosriboflavin ophthalmic solution
GlaukosNXL Energy 1
Clinical Trials (3)
Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive Keratoconus
Start: Apr 2018Est. completion: Aug 2020
Phase 3Completed
Corneal Collagen Cross-linking for Progressive Keratoconus
Start: Dec 2007Est. completion: Apr 2011
Phase 3Completed
Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus
Start: Mar 2022Est. completion: Feb 2026
Phase 1/2Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 late-stage (Phase 3) programs — potential near-term approvals
1 actively recruiting trials
1 companies competing in this space